carboxylesterase-expressing allogeneic neural stem cells
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 30, 2014 (NCT02055196)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- carboxylesterase-expressing allogeneic neural stem cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02192359 | Phase 1 | Mar 7, 2016 | City of Hope National Medical Center, National Cancer Institute (NCI) |
| NCT02055196 | Phase 1 | Jan 30, 2014 | City of Hope National Medical Center, National Cancer Institute (NCI) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| City of Hope National Medical Center | Academic/Hospital | 2 | 2 | 1 | 2014 |
| National Cancer Institute (NCI) | Government | 2 | 0 | 1 | 2014 |
2 organizations
Page 1 / 1